Pneumococcal synergism

Aus coViki
Wechseln zu: Navigation, Suche

Pneumococcal colonization means synergism with sars cov2 ad disease expression. 13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. 13-valent vaccination reduces surface colonization by pneumococci, 23 valent does not.

relevant pubmed items now included; pmcentral w. low specificity at 2953 total remaining to be included

this bibliography has been forwarded to P.M. Mori, Bundeskanzlerin Merkel, Gesundheitsminister Spahn, Prof. Montgomery on April 26th 2021.

index paper is

33693636 2021. Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract

until further humanized work by me,

living current stringent pubmed readout on covid19 & pneumococci


Antibiotics or Pneumococcal Vaccination and Co-Infections

33140176 ä. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship
33010444 2021. Recommendations for antibacterial therapy in adults with COVID-19 ? an evidence based guideline
32194236 2020. Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?
32482366 2020. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
33419872 2021. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV
32600911 2020. Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality
33637783 2021. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
33588980 2021. Exploration of Association between Respiratory Vaccinations with Infection and Mortality Rates of COVID-19
33724440 2021. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
32869330 2020. Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
32940090 2020. (any target vacc or cov2 vavv) Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations
32842505 2020. The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey
32987794 2020. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

On Pneumococcal Co-Infections

33449815 2021. Pneumococcal carriage in children with COVID-19
33883479 2021. Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study
33138045 2020. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decre